DE602004015141D1 - Modifizierte ganzzell-, zellextrakt- und omv-basierte impfstoffe - Google Patents
Modifizierte ganzzell-, zellextrakt- und omv-basierte impfstoffeInfo
- Publication number
- DE602004015141D1 DE602004015141D1 DE602004015141T DE602004015141T DE602004015141D1 DE 602004015141 D1 DE602004015141 D1 DE 602004015141D1 DE 602004015141 T DE602004015141 T DE 602004015141T DE 602004015141 T DE602004015141 T DE 602004015141T DE 602004015141 D1 DE602004015141 D1 DE 602004015141D1
- Authority
- DE
- Germany
- Prior art keywords
- vaccines
- zelextract
- omv
- whole cell
- based vaccines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229960005486 vaccine Drugs 0.000 title abstract 5
- 108010062802 CD66 antigens Proteins 0.000 abstract 2
- 102100024533 Carcinoembryonic antigen-related cell adhesion molecule 1 Human genes 0.000 abstract 2
- 241000040340 Oat mosaic virus Species 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 229940124590 live attenuated vaccine Drugs 0.000 abstract 1
- 229940023012 live-attenuated vaccine Drugs 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0323709.6A GB0323709D0 (en) | 2003-10-09 | 2003-10-09 | Modified whole cell,cell extract and omv-based vaccines |
| PCT/GB2004/004274 WO2005035733A2 (en) | 2003-10-09 | 2004-10-08 | Modified whole cell, cell extract and omv-based vaccines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602004015141D1 true DE602004015141D1 (de) | 2008-08-28 |
Family
ID=29433617
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602004015141T Expired - Lifetime DE602004015141D1 (de) | 2003-10-09 | 2004-10-08 | Modifizierte ganzzell-, zellextrakt- und omv-basierte impfstoffe |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20070154495A1 (de) |
| EP (1) | EP1687011B1 (de) |
| JP (1) | JP2007508537A (de) |
| AT (1) | ATE401091T1 (de) |
| AU (1) | AU2004279990B2 (de) |
| CA (1) | CA2541834C (de) |
| DE (1) | DE602004015141D1 (de) |
| DK (1) | DK1687011T3 (de) |
| ES (1) | ES2310753T3 (de) |
| GB (1) | GB0323709D0 (de) |
| PT (1) | PT1687011E (de) |
| WO (1) | WO2005035733A2 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011027971A2 (ko) * | 2009-09-01 | 2011-03-10 | 주식회사이언메딕스 | 장내 공생 세균유래 세포밖 소포체, 및 이를 이용한 질병모델, 백신, 후보 약물 탐색 방법, 및 진단 방법 |
| WO2011027956A2 (ko) | 2009-09-04 | 2011-03-10 | 주식회사이언메딕스 | 그람 양성 박테리아에서 유래한 세포밖 소포체 및 이를 이용한 질병 모델 |
| EP2486940B1 (de) * | 2009-10-08 | 2017-10-04 | Aeon Medix Inc. | Zusammensetzungen mit aus raumluft gewonnenen extrazellulären membran-vesikeln und verwendung davon |
| JP2011169834A (ja) * | 2010-02-19 | 2011-09-01 | Kansai Bunri Sogo Gakuen | 病原性グラム陰性細菌由来脂質小胞の検出方法および検出システム |
| KR20160101521A (ko) * | 2015-02-17 | 2016-08-25 | 이화여자대학교 산학협력단 | 세균 유래 세포밖 소포체를 이용한 호흡기 염증성 질환의 진단방법 |
| JP7104027B2 (ja) * | 2016-09-02 | 2022-07-20 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 淋菌に対するワクチン |
| US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6558677B2 (en) * | 1996-10-15 | 2003-05-06 | Wendell D. Zollinger | Vaccine against gram negative bacteria |
| GB0130123D0 (en) * | 2001-12-17 | 2002-02-06 | Microbiological Res Agency | Outer membrane vesicle vaccine and its preparation |
| ES2575014T3 (es) * | 2002-08-02 | 2016-06-23 | Glaxosmithkline Biologicals S.A. | Composiciones de vacuna contra Neisseria que comprenden una combinación de antígenos |
-
2003
- 2003-10-09 GB GBGB0323709.6A patent/GB0323709D0/en not_active Ceased
-
2004
- 2004-10-08 EP EP04768807A patent/EP1687011B1/de not_active Expired - Lifetime
- 2004-10-08 WO PCT/GB2004/004274 patent/WO2005035733A2/en active IP Right Grant
- 2004-10-08 AT AT04768807T patent/ATE401091T1/de active
- 2004-10-08 JP JP2006530598A patent/JP2007508537A/ja active Pending
- 2004-10-08 US US10/575,070 patent/US20070154495A1/en not_active Abandoned
- 2004-10-08 DE DE602004015141T patent/DE602004015141D1/de not_active Expired - Lifetime
- 2004-10-08 CA CA2541834A patent/CA2541834C/en not_active Expired - Fee Related
- 2004-10-08 AU AU2004279990A patent/AU2004279990B2/en not_active Ceased
- 2004-10-08 DK DK04768807T patent/DK1687011T3/da active
- 2004-10-08 PT PT04768807T patent/PT1687011E/pt unknown
- 2004-10-08 ES ES04768807T patent/ES2310753T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ATE401091T1 (de) | 2008-08-15 |
| EP1687011B1 (de) | 2008-07-16 |
| CA2541834C (en) | 2012-09-04 |
| GB0323709D0 (en) | 2003-11-12 |
| US20070154495A1 (en) | 2007-07-05 |
| AU2004279990B2 (en) | 2010-04-01 |
| CA2541834A1 (en) | 2005-04-21 |
| AU2004279990A1 (en) | 2005-04-21 |
| EP1687011A2 (de) | 2006-08-09 |
| WO2005035733A2 (en) | 2005-04-21 |
| PT1687011E (pt) | 2008-10-28 |
| DK1687011T3 (da) | 2008-11-10 |
| JP2007508537A (ja) | 2007-04-05 |
| ES2310753T3 (es) | 2009-01-16 |
| WO2005035733A3 (en) | 2005-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201000424A1 (ru) | Антитела к il-23 | |
| NO20023829L (no) | Proteosom influensavaksine | |
| ECSP066683A (es) | Vacuna para mejorar el crecimiento, a base de epítopes neutralizantes | |
| CR8231A (es) | Anticuerpos rg1 y uso de los mismos | |
| ATE454901T1 (de) | Verfahren zur erhaltung zellimmuneantworten gegen proteinen | |
| CR7875A (es) | Variantes de inmunoglobina y usos de esto | |
| BRPI0607605A2 (pt) | moléculas imunogênicas | |
| MXPA02005639A (es) | Induccion de respuestas celulares iinmunologicas al virus de papiloma humano y utilizacion de composiciones de peptidos y acidos nucleico. | |
| MA33757B1 (fr) | Protéines de liaison à l'antigène de l'il-23 humaine | |
| SI1957539T1 (sl) | Humana monoklonska protitelesa proti protein tirozin kinazi 7 (PTK7) in njihova uporaba | |
| EA200870129A1 (ru) | Человеческие антитела против il-23, композиции, способы и применение | |
| SI1644484T1 (sl) | Avtologne samo-toleranco inducirajoče celice monocitnega izvora in njihova uporaba v farmacevtskihpripravah | |
| EA200602137A1 (ru) | Гидрогелевые препараты интерферона | |
| ATE460176T1 (de) | Mikrosomvakzin | |
| NO20062044L (no) | Piscirickettsia salmonis-antigener og anvendelse derav | |
| EA200600065A2 (ru) | Гидрофобные композиционные и сыпучие материалы, их применение | |
| ATE513561T1 (de) | Veränderung des th1/th2-gleichgewichts in spalt- grippeimpfstoffen mit adjuvantien | |
| ATE517340T1 (de) | Sätze gegen kurze epitope gerichteter digitaler antikörper sowie diese verwendende verfahren | |
| RU2014135406A (ru) | Модифицированные эпитопы для усиления ответов cd4+ т-клеток | |
| DK1572087T3 (da) | Antistoffer med cancerantigen TMEFF2 og anvendelser deraf | |
| MEP20908A (en) | Thienopyrazoles | |
| DE602004015141D1 (de) | Modifizierte ganzzell-, zellextrakt- und omv-basierte impfstoffe | |
| TR200102034T2 (tr) | Anti kanser aşılaması için antikorların kullanılması | |
| EA200970731A1 (ru) | Рекомбинантные антигены цитомегаловируса человека (hcmv) | |
| DK1290160T3 (da) | Humane Pellino-polypeptider |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |